Congress bans animal research, but delays drug testing rules three years
H.R. 1802 — SPARE Act · Filed by Nicole Malliotakis (R-NY) · 2 cosponsors · Introduced Mar 3, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill prohibits the use of animals in federally funded research, with delayed timelines for different research types (18 months for cosmetics/toxicity testing, 3 years for drug testing) and narrow exceptions for veterinary care, military/service animals, and infectious disease or national security research approved by Congress. It establishes a $-funded modernization program to transition research to non-animal alternatives, requires facilities to rehome retired research animals, and creates public reporting and audit mechanisms.
Why we flagged it
The bill's core mechanism is a federal prohibition on animal research funding with phase-in periods and exceptions, paired with a modernization fund to support transition to non-animal methods. This is substantively an animal-welfare and research-modernization measure, not a deregulation or corporate carve-out.
What the text implies
- The 3-year delay for drug/biomedical testing may create a gap period where federally funded researchers continue animal testing while non-animal alternatives are still being validated and standardized, potentially extending animal use rather than accelerating its phase-out.
- Congressional authorization requirement for infectious disease and national security research effectively gives Congress veto power over specific animal research projects, centralizing research decisions in a legislative body rather than scientific/regulatory bodies, which may slow emergency response research.
- The bill does not specify funding levels for the Federal Research Modernization Fund, leaving the transition support mechanism potentially underfunded relative to the scope of research being prohibited.
- Facilities must release animals within one year, but the bill does not mandate funding for animal care during transition, potentially creating financial burden on rescue organizations and sanctuaries.
- The public database requirement may expose proprietary research information or facility locations, creating potential security or privacy concerns for researchers and facilities.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
Citizens benefit from reduced tax spending on animal research, alignment with stated ethical goals, and animal welfare protections. However, the 3-year delay on drug/biomedical testing and the requirement for Congressional approval of any remaining animal research may slow medical innovation and drug development timelines, potentially delaying treatments for serious diseases.
Who stands to gain
- non-animal research technology companies (organ-on-chip, AI-based modeling, human cell-based systems
- animal rescue organizations and sanctuaries (receiving animals and potentially grant funding)
- non-profit research institutions transitioning to alternative methods
Named in the bill
National Science Foundation, National Institutes of Health, Department of Agriculture, Animal and Plant Health Inspection Service, Office of Laboratory Animal Welfare, Global Federation of Animal Sanctuaries, Federal contractors and grantees, Comptroller General of the United States
Where it stands
2 cosponsors: 2 Republicans.
- Mar 3, 2025 — Introduced · Congress.gov: “Introduced in House”
- Mar 3, 2025 — Referred to House Committee on Rules and House Committee on Agriculture · Congress.gov: “Referred to the Committee on Science, Space, and Technology, and in addition to the Committees on Energy and…”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
Money around this bill
7 lobbying clients named this bill on 35 disclosure filings across 7 quarters, Mar 2025 to Sep 2026. Those filings disclosed $7,808,603 in lobbying spend. A filing names 25 bills on average, so that figure is what each filing reported, not a share belonging to this bill.
More lobbying clients named this bill than 83% of bills with at least one filing.
Nicole Malliotakis, the sponsor, reported $1,258,250 in PAC receipts in the 2026 cycle.
- Association of American Medical Colleges — $4,128,603 on 6 filings
- American Psychological Association Services Inc.(fka American Psychological Assn — $2,800,000 on 7 filings
- Rutgers the State University of New Jersey — $570,000 on 6 filings
- College on Problems of Drug Dependence — $150,000 on 7 filings
- Federation of American Societies for Experimental Biology — $80,000 on 1 filing
Lobbying Disclosure Act filings through Oct 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (12,023 characters) on Nov 15, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 17,910 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Mar 2025 to Sep 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.
As of — lobbying records through Oct 20, 2026 · page rendered 2026-11-22.
- H.R. 1802 on Congress.gov
- Actions and status history
- Cosponsors (2)
- Bill text the analysis read
- Association of American Medical Colleges — LDA filing, 2025 Q2
- American Psychological Association Services Inc.(fka American Psychological Assn — LDA filing, 2026 Q1
- Rutgers the State University of New Jersey — LDA filing, 2026 Q1
- Nicole Malliotakis — FEC candidate receipts, 2026 cycle
“Congress bans animal research, but delays drug testing rules three years” QuorumCivic. https://share.quorumcivic.app/bill/119/hr1802 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.